Each compound targets distinct neurobiological pathwaysneurotrophism (BDNF), GABAergic modulation, neurotransmitter regulation, or sleep architecture
Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion
TABLE 2 Compound ( 10 ' 12 M) HGF Mimetic Activity N- heptanoyl-Tyr-Ile-(6) aminohexamide N- hexanoyl-Tyr-Ile-(6) aminohexamide ++++ N- pentaanoyl-Tyr-Ile-(6) aminohexamide _j N- butanoyl-Tyr-Ile-(6) aminohexamide +++ N- propananoyl-Tyr-Ile-(6) aminohexamide ++ N- acetanoyl-Tyr-Ile-(6) aminohexamide + N- benzoyl-Tyr-Ue-(6) aminohexamide + N- hexanoyl- (CH 2 -NIT 2 )-Tyr-Ile-(6) aminohexamide +++ Cell culture
Important Administration Tips Begin on a small dose and observe reaction
This receptor is expressed not only in neurons and astrocytes but also in microglia, and preclinical studies have demonstrated that A 2A receptor antagonists exert robust neuroprotective effects across multiple animal models of neurodegeneration, including both AD and PD [474478]
In rats, DSIP stops somatostatin release through dopamine pathways, which could indirectly increase growth hormone (GH) (8)